vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $88.2M, roughly 1.4× FIRST MID BANCSHARES, INC.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs 3.3%, a 23.5% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 3.4%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 5.0%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
FMBH vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $123.8M |
| Net Profit | $23.7M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 34.0% | 4.3% |
| Net Margin | 26.8% | 3.3% |
| Revenue YoY | 3.4% | 4.7% |
| Net Profit YoY | 23.5% | 1379.4% |
| EPS (diluted) | $0.98 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $123.8M | ||
| Q3 25 | $89.3M | $128.3M | ||
| Q2 25 | $87.5M | $114.8M | ||
| Q1 25 | $84.3M | $113.2M | ||
| Q4 24 | $85.3M | $118.2M | ||
| Q3 24 | $80.6M | $114.6M | ||
| Q2 24 | $79.2M | $110.6M | ||
| Q1 24 | $79.9M | $111.0M |
| Q4 25 | $23.7M | $4.1M | ||
| Q3 25 | $22.5M | $5.3M | ||
| Q2 25 | $23.4M | $5.3M | ||
| Q1 25 | $22.2M | $4.7M | ||
| Q4 24 | $19.2M | $-321.0K | ||
| Q3 24 | $19.5M | $4.3M | ||
| Q2 24 | $19.7M | $1.3M | ||
| Q1 24 | $20.5M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | 34.0% | 4.3% | ||
| Q3 25 | 32.2% | 7.0% | ||
| Q2 25 | 34.4% | 3.7% | ||
| Q1 25 | 33.4% | 5.4% | ||
| Q4 24 | 29.7% | 3.8% | ||
| Q3 24 | 31.5% | 4.6% | ||
| Q2 24 | 33.7% | 5.1% | ||
| Q1 24 | 33.7% | 4.2% |
| Q4 25 | 26.8% | 3.3% | ||
| Q3 25 | 25.2% | 4.2% | ||
| Q2 25 | 26.8% | 4.6% | ||
| Q1 25 | 26.3% | 4.2% | ||
| Q4 24 | 22.5% | -0.3% | ||
| Q3 24 | 24.2% | 3.8% | ||
| Q2 24 | 24.9% | 1.2% | ||
| Q1 24 | 25.6% | 2.1% |
| Q4 25 | $0.98 | $0.23 | ||
| Q3 25 | $0.94 | $0.30 | ||
| Q2 25 | $0.98 | $0.28 | ||
| Q1 25 | $0.93 | $0.25 | ||
| Q4 24 | $0.81 | $-0.02 | ||
| Q3 24 | $0.81 | $0.23 | ||
| Q2 24 | $0.82 | $0.07 | ||
| Q1 24 | $0.86 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.9M |
| Total DebtLower is stronger | $354.5M | — |
| Stockholders' EquityBook value | $958.7M | $161.6M |
| Total Assets | $8.0B | $261.1M |
| Debt / EquityLower = less leverage | 0.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | — | $81.3M | ||
| Q1 25 | — | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | — | $78.7M | ||
| Q2 24 | — | $68.7M | ||
| Q1 24 | — | $77.8M |
| Q4 25 | $354.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | $958.7M | $161.6M | ||
| Q3 25 | $932.2M | $166.7M | ||
| Q2 25 | $894.1M | $163.7M | ||
| Q1 25 | $870.9M | $167.1M | ||
| Q4 24 | $846.4M | $161.0M | ||
| Q3 24 | $858.5M | $162.6M | ||
| Q2 24 | $813.6M | $156.4M | ||
| Q1 24 | $798.0M | $159.7M |
| Q4 25 | $8.0B | $261.1M | ||
| Q3 25 | $7.8B | $264.8M | ||
| Q2 25 | $7.7B | $254.9M | ||
| Q1 25 | $7.6B | $252.7M | ||
| Q4 24 | $7.5B | $240.9M | ||
| Q3 24 | $7.6B | $245.3M | ||
| Q2 24 | $7.6B | $235.8M | ||
| Q1 24 | $7.7B | $247.3M |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $9.9M |
| Free Cash FlowOCF − Capex | $124.0M | $7.6M |
| FCF MarginFCF / Revenue | 140.6% | 6.1% |
| Capex IntensityCapex / Revenue | 7.8% | 1.9% |
| Cash ConversionOCF / Net Profit | 5.53× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $9.9M | ||
| Q3 25 | $33.0M | $18.5M | ||
| Q2 25 | $7.7M | $4.3M | ||
| Q1 25 | $47.9M | $2.6M | ||
| Q4 24 | $124.4M | $12.2M | ||
| Q3 24 | $33.1M | $9.6M | ||
| Q2 24 | $24.0M | $1.3M | ||
| Q1 24 | $29.0M | $2.2M |
| Q4 25 | $124.0M | $7.6M | ||
| Q3 25 | $31.9M | $16.8M | ||
| Q2 25 | $6.0M | $3.0M | ||
| Q1 25 | $46.0M | $1.5M | ||
| Q4 24 | $119.5M | $10.0M | ||
| Q3 24 | $32.0M | $7.9M | ||
| Q2 24 | $22.9M | $-2.0M | ||
| Q1 24 | $27.6M | $-1.5M |
| Q4 25 | 140.6% | 6.1% | ||
| Q3 25 | 35.8% | 13.1% | ||
| Q2 25 | 6.8% | 2.6% | ||
| Q1 25 | 54.5% | 1.3% | ||
| Q4 24 | 140.0% | 8.5% | ||
| Q3 24 | 39.7% | 6.9% | ||
| Q2 24 | 28.9% | -1.9% | ||
| Q1 24 | 34.5% | -1.4% |
| Q4 25 | 7.8% | 1.9% | ||
| Q3 25 | 1.2% | 1.3% | ||
| Q2 25 | 2.0% | 1.2% | ||
| Q1 25 | 2.3% | 1.0% | ||
| Q4 24 | 5.8% | 1.9% | ||
| Q3 24 | 1.4% | 1.5% | ||
| Q2 24 | 1.4% | 3.0% | ||
| Q1 24 | 1.9% | 3.3% |
| Q4 25 | 5.53× | 2.41× | ||
| Q3 25 | 1.47× | 3.46× | ||
| Q2 25 | 0.33× | 0.81× | ||
| Q1 25 | 2.16× | 0.55× | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | 1.70× | 2.21× | ||
| Q2 24 | 1.21× | 0.97× | ||
| Q1 24 | 1.42× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMBH
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
